Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke

Completed · Phase 2 · Has a placebo group

Conditions studied: Stroke

In brief

The purpose of this study is to determine whether pomegranate supplements improve cognitive functioning following stroke.

Key facts

Study ID

NCT02442804

Run by

Loma Linda University

People needed

16

Starts

2015-06-01

Expected to finish

2016-04-01

Last updated by the study team

2017-08-02

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Suffered an ischemic stroke and admitted to LLUMC Rehabilitation Institute for inpatient care
• Fluent in English
• Between the age of 18 and 89 years old

You may not qualify if…

• Less than 6 years of education
• Global aphasia
• Pregnant
• History of allergy to pomegranates
• History of traumatic brain injury
• Neurodegenerative disease or neurologic condition with known cognitive impact (e.g., Alzheimer's disease)
• Active renal disease
• Active liver disease
• Intracerebral hemorrhage in past 6 months
• Neurosurgery in past month
• Taking warfarin (Coumadin)

Where it is running

• Loma Linda University East Campus Hospital — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.